Cancer BiologyNature CommunicationsPeer-reviewed
ELOVL6 as a Therapeutic Target: Disrupting c-MYC-Driven Lipid Metabolism to Enhance Chemotherapy in Pancreatic Cancer
Ana García García, María Ferrer Aporta, Germán Vallejo-Palma…·Victor Javier Sanchez-Arevalo Lobo
This study identifies ELOVL6 as a therapeutic target in pancreatic cancer by showing its role in c-MYC-driven lipid metabolism and its impact on chemotherapy efficacy.